Antares Pharma, Inc. (ATRS)

EBITDA Growth

-132.59%

Quarterly · Period ending:

ATRS logo

ATRS EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-132.59%
ATRS Quarterly EBITDA YoY % (-40.00% → -132.59%)
High-resolution chart · PNG

ATRS ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. EBITDA Growth — Quarterly
Period endingEBITDA Growth
-40%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.